Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
22/12/2017
12/12/2017
29/11/2017
24/11/2017
25/10/2017
25/10/2017
18/10/2017
28/09/2017
26/09/2017
18/09/2017
18/09/2017
30/08/2017
30/08/2017
29/08/2017
28/08/2017
28/08/2017
10/08/2017
13/07/2017
30/06/2017
30/06/2017
20/06/2017
20/06/2017
19/06/2017
07/06/2017
26/05/2017
15/05/2017
08/05/2017
08/05/2017
23/03/2017
23/03/2017